Copyright Reports & Markets. All rights reserved.

Global Poultry Necrotic Enteritis Drugs Market Insights, Forecast to 2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Poultry Necrotic Enteritis Drugs Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Poultry Necrotic Enteritis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 Inter Alpha Inhibitor Proteins
      • 1.2.3 Antibiotics
      • 1.2.4 Dietary Supplements
    • 1.3 Market by Application
      • 1.3.1 Global Poultry Necrotic Enteritis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Hospital Pharmacies
      • 1.3.3 Retail Pharmacies
      • 1.3.4 Online Pharmacies
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global Poultry Necrotic Enteritis Drugs Sales Estimates and Forecasts 2017-2028
    • 2.2 Global Poultry Necrotic Enteritis Drugs Revenue Estimates and Forecasts 2017-2028
    • 2.3 Global Poultry Necrotic Enteritis Drugs Revenue by Region: 2017 VS 2021 VS 2028
    • 2.4 Global Poultry Necrotic Enteritis Drugs Sales by Region
      • 2.4.1 Global Poultry Necrotic Enteritis Drugs Sales by Region (2017-2022)
      • 2.4.2 Global Sales Poultry Necrotic Enteritis Drugs by Region (2023-2028)
    • 2.5 Global Poultry Necrotic Enteritis Drugs Revenue by Region
      • 2.5.1 Global Poultry Necrotic Enteritis Drugs Revenue by Region (2017-2022)
      • 2.5.2 Global Poultry Necrotic Enteritis Drugs Revenue by Region (2023-2028)
    • 2.6 North America
    • 2.7 Europe
    • 2.8 Asia-Pacific
    • 2.9 Latin America
    • 2.10 Middle East & Africa

    3 Competition by Manufacturers

    • 3.1 Global Poultry Necrotic Enteritis Drugs Sales by Manufacturers
      • 3.1.1 Global Top Poultry Necrotic Enteritis Drugs Manufacturers by Sales (2017-2022)
      • 3.1.2 Global Poultry Necrotic Enteritis Drugs Sales Market Share by Manufacturers (2017-2022)
      • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Poultry Necrotic Enteritis Drugs in 2021
    • 3.2 Global Poultry Necrotic Enteritis Drugs Revenue by Manufacturers
      • 3.2.1 Global Poultry Necrotic Enteritis Drugs Revenue by Manufacturers (2017-2022)
      • 3.2.2 Global Poultry Necrotic Enteritis Drugs Revenue Market Share by Manufacturers (2017-2022)
      • 3.2.3 Global Top 10 and Top 5 Companies by Poultry Necrotic Enteritis Drugs Revenue in 2021
    • 3.3 Global Poultry Necrotic Enteritis Drugs Sales Price by Manufacturers (2017-2022)
    • 3.4 Analysis of Competitive Landscape
      • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Poultry Necrotic Enteritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      • 3.4.3 Global Poultry Necrotic Enteritis Drugs Manufacturers Geographical Distribution
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Global Poultry Necrotic Enteritis Drugs Sales by Type
      • 4.1.1 Global Poultry Necrotic Enteritis Drugs Historical Sales by Type (2017-2022)
      • 4.1.2 Global Poultry Necrotic Enteritis Drugs Forecasted Sales by Type (2023-2028)
      • 4.1.3 Global Poultry Necrotic Enteritis Drugs Sales Market Share by Type (2017-2028)
    • 4.2 Global Poultry Necrotic Enteritis Drugs Revenue by Type
      • 4.2.1 Global Poultry Necrotic Enteritis Drugs Historical Revenue by Type (2017-2022)
      • 4.2.2 Global Poultry Necrotic Enteritis Drugs Forecasted Revenue by Type (2023-2028)
      • 4.2.3 Global Poultry Necrotic Enteritis Drugs Revenue Market Share by Type (2017-2028)
    • 4.3 Global Poultry Necrotic Enteritis Drugs Price by Type
      • 4.3.1 Global Poultry Necrotic Enteritis Drugs Price by Type (2017-2022)
      • 4.3.2 Global Poultry Necrotic Enteritis Drugs Price Forecast by Type (2023-2028)

    5 Market Size by Application

    • 5.1 Global Poultry Necrotic Enteritis Drugs Sales by Application
      • 5.1.1 Global Poultry Necrotic Enteritis Drugs Historical Sales by Application (2017-2022)
      • 5.1.2 Global Poultry Necrotic Enteritis Drugs Forecasted Sales by Application (2023-2028)
      • 5.1.3 Global Poultry Necrotic Enteritis Drugs Sales Market Share by Application (2017-2028)
    • 5.2 Global Poultry Necrotic Enteritis Drugs Revenue by Application
      • 5.2.1 Global Poultry Necrotic Enteritis Drugs Historical Revenue by Application (2017-2022)
      • 5.2.2 Global Poultry Necrotic Enteritis Drugs Forecasted Revenue by Application (2023-2028)
      • 5.2.3 Global Poultry Necrotic Enteritis Drugs Revenue Market Share by Application (2017-2028)
    • 5.3 Global Poultry Necrotic Enteritis Drugs Price by Application
      • 5.3.1 Global Poultry Necrotic Enteritis Drugs Price by Application (2017-2022)
      • 5.3.2 Global Poultry Necrotic Enteritis Drugs Price Forecast by Application (2023-2028)

    6 North America

    • 6.1 North America Poultry Necrotic Enteritis Drugs Market Size by Type
      • 6.1.1 North America Poultry Necrotic Enteritis Drugs Sales by Type (2017-2028)
      • 6.1.2 North America Poultry Necrotic Enteritis Drugs Revenue by Type (2017-2028)
    • 6.2 North America Poultry Necrotic Enteritis Drugs Market Size by Application
      • 6.2.1 North America Poultry Necrotic Enteritis Drugs Sales by Application (2017-2028)
      • 6.2.2 North America Poultry Necrotic Enteritis Drugs Revenue by Application (2017-2028)
    • 6.3 North America Poultry Necrotic Enteritis Drugs Market Size by Country
      • 6.3.1 North America Poultry Necrotic Enteritis Drugs Sales by Country (2017-2028)
      • 6.3.2 North America Poultry Necrotic Enteritis Drugs Revenue by Country (2017-2028)
      • 6.3.3 United States
      • 6.3.4 Canada

    7 Europe

    • 7.1 Europe Poultry Necrotic Enteritis Drugs Market Size by Type
      • 7.1.1 Europe Poultry Necrotic Enteritis Drugs Sales by Type (2017-2028)
      • 7.1.2 Europe Poultry Necrotic Enteritis Drugs Revenue by Type (2017-2028)
    • 7.2 Europe Poultry Necrotic Enteritis Drugs Market Size by Application
      • 7.2.1 Europe Poultry Necrotic Enteritis Drugs Sales by Application (2017-2028)
      • 7.2.2 Europe Poultry Necrotic Enteritis Drugs Revenue by Application (2017-2028)
    • 7.3 Europe Poultry Necrotic Enteritis Drugs Market Size by Country
      • 7.3.1 Europe Poultry Necrotic Enteritis Drugs Sales by Country (2017-2028)
      • 7.3.2 Europe Poultry Necrotic Enteritis Drugs Revenue by Country (2017-2028)
      • 7.3.3 Germany
      • 7.3.4 France
      • 7.3.5 U.K.
      • 7.3.6 Italy
      • 7.3.7 Russia

    8 Asia Pacific

    • 8.1 Asia Pacific Poultry Necrotic Enteritis Drugs Market Size by Type
      • 8.1.1 Asia Pacific Poultry Necrotic Enteritis Drugs Sales by Type (2017-2028)
      • 8.1.2 Asia Pacific Poultry Necrotic Enteritis Drugs Revenue by Type (2017-2028)
    • 8.2 Asia Pacific Poultry Necrotic Enteritis Drugs Market Size by Application
      • 8.2.1 Asia Pacific Poultry Necrotic Enteritis Drugs Sales by Application (2017-2028)
      • 8.2.2 Asia Pacific Poultry Necrotic Enteritis Drugs Revenue by Application (2017-2028)
    • 8.3 Asia Pacific Poultry Necrotic Enteritis Drugs Market Size by Region
      • 8.3.1 Asia Pacific Poultry Necrotic Enteritis Drugs Sales by Region (2017-2028)
      • 8.3.2 Asia Pacific Poultry Necrotic Enteritis Drugs Revenue by Region (2017-2028)
      • 8.3.3 China
      • 8.3.4 Japan
      • 8.3.5 South Korea
      • 8.3.6 India
      • 8.3.7 Australia
      • 8.3.8 China Taiwan
      • 8.3.9 Indonesia
      • 8.3.10 Thailand
      • 8.3.11 Malaysia

    9 Latin America

    • 9.1 Latin America Poultry Necrotic Enteritis Drugs Market Size by Type
      • 9.1.1 Latin America Poultry Necrotic Enteritis Drugs Sales by Type (2017-2028)
      • 9.1.2 Latin America Poultry Necrotic Enteritis Drugs Revenue by Type (2017-2028)
    • 9.2 Latin America Poultry Necrotic Enteritis Drugs Market Size by Application
      • 9.2.1 Latin America Poultry Necrotic Enteritis Drugs Sales by Application (2017-2028)
      • 9.2.2 Latin America Poultry Necrotic Enteritis Drugs Revenue by Application (2017-2028)
    • 9.3 Latin America Poultry Necrotic Enteritis Drugs Market Size by Country
      • 9.3.1 Latin America Poultry Necrotic Enteritis Drugs Sales by Country (2017-2028)
      • 9.3.2 Latin America Poultry Necrotic Enteritis Drugs Revenue by Country (2017-2028)
      • 9.3.3 Mexico
      • 9.3.4 Brazil
      • 9.3.5 Argentina
      • 9.3.6 Colombia

    10 Middle East and Africa

    • 10.1 Middle East and Africa Poultry Necrotic Enteritis Drugs Market Size by Type
      • 10.1.1 Middle East and Africa Poultry Necrotic Enteritis Drugs Sales by Type (2017-2028)
      • 10.1.2 Middle East and Africa Poultry Necrotic Enteritis Drugs Revenue by Type (2017-2028)
    • 10.2 Middle East and Africa Poultry Necrotic Enteritis Drugs Market Size by Application
      • 10.2.1 Middle East and Africa Poultry Necrotic Enteritis Drugs Sales by Application (2017-2028)
      • 10.2.2 Middle East and Africa Poultry Necrotic Enteritis Drugs Revenue by Application (2017-2028)
    • 10.3 Middle East and Africa Poultry Necrotic Enteritis Drugs Market Size by Country
      • 10.3.1 Middle East and Africa Poultry Necrotic Enteritis Drugs Sales by Country (2017-2028)
      • 10.3.2 Middle East and Africa Poultry Necrotic Enteritis Drugs Revenue by Country (2017-2028)
      • 10.3.3 Turkey
      • 10.3.4 Saudi Arabia

    11 Company Profiles

    • 11.1 Prometic Life Sciences
      • 11.1.1 Prometic Life Sciences Corporation Information
      • 11.1.2 Prometic Life Sciences Overview
      • 11.1.3 Prometic Life Sciences Poultry Necrotic Enteritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.1.4 Prometic Life Sciences Poultry Necrotic Enteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.1.5 Prometic Life Sciences Recent Developments
    • 11.2 BioGaia Probiotics
      • 11.2.1 BioGaia Probiotics Corporation Information
      • 11.2.2 BioGaia Probiotics Overview
      • 11.2.3 BioGaia Probiotics Poultry Necrotic Enteritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.2.4 BioGaia Probiotics Poultry Necrotic Enteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.2.5 BioGaia Probiotics Recent Developments
    • 11.3 Fresenius
      • 11.3.1 Fresenius Corporation Information
      • 11.3.2 Fresenius Overview
      • 11.3.3 Fresenius Poultry Necrotic Enteritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.3.4 Fresenius Poultry Necrotic Enteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.3.5 Fresenius Recent Developments
    • 11.4 Actavis
      • 11.4.1 Actavis Corporation Information
      • 11.4.2 Actavis Overview
      • 11.4.3 Actavis Poultry Necrotic Enteritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.4.4 Actavis Poultry Necrotic Enteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.4.5 Actavis Recent Developments
    • 11.5 Teva
      • 11.5.1 Teva Corporation Information
      • 11.5.2 Teva Overview
      • 11.5.3 Teva Poultry Necrotic Enteritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.5.4 Teva Poultry Necrotic Enteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.5.5 Teva Recent Developments
    • 11.6 Bayer International
      • 11.6.1 Bayer International Corporation Information
      • 11.6.2 Bayer International Overview
      • 11.6.3 Bayer International Poultry Necrotic Enteritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.6.4 Bayer International Poultry Necrotic Enteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.6.5 Bayer International Recent Developments
    • 11.7 Alcon
      • 11.7.1 Alcon Corporation Information
      • 11.7.2 Alcon Overview
      • 11.7.3 Alcon Poultry Necrotic Enteritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.7.4 Alcon Poultry Necrotic Enteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.7.5 Alcon Recent Developments
    • 11.8 GlaxoSmithKline
      • 11.8.1 GlaxoSmithKline Corporation Information
      • 11.8.2 GlaxoSmithKline Overview
      • 11.8.3 GlaxoSmithKline Poultry Necrotic Enteritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.8.4 GlaxoSmithKline Poultry Necrotic Enteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.8.5 GlaxoSmithKline Recent Developments
    • 11.9 Bausch & Lomb Incorporated
      • 11.9.1 Bausch & Lomb Incorporated Corporation Information
      • 11.9.2 Bausch & Lomb Incorporated Overview
      • 11.9.3 Bausch & Lomb Incorporated Poultry Necrotic Enteritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.9.4 Bausch & Lomb Incorporated Poultry Necrotic Enteritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.9.5 Bausch & Lomb Incorporated Recent Developments

    12 Industry Chain and Sales Channels Analysis

    • 12.1 Poultry Necrotic Enteritis Drugs Industry Chain Analysis
    • 12.2 Poultry Necrotic Enteritis Drugs Key Raw Materials
      • 12.2.1 Key Raw Materials
      • 12.2.2 Raw Materials Key Suppliers
    • 12.3 Poultry Necrotic Enteritis Drugs Production Mode & Process
    • 12.4 Poultry Necrotic Enteritis Drugs Sales and Marketing
      • 12.4.1 Poultry Necrotic Enteritis Drugs Sales Channels
      • 12.4.2 Poultry Necrotic Enteritis Drugs Distributors
    • 12.5 Poultry Necrotic Enteritis Drugs Customers

    13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    • 13.1 Poultry Necrotic Enteritis Drugs Industry Trends
    • 13.2 Poultry Necrotic Enteritis Drugs Market Drivers
    • 13.3 Poultry Necrotic Enteritis Drugs Market Challenges
    • 13.4 Poultry Necrotic Enteritis Drugs Market Restraints

    14 Key Findings in The Global Poultry Necrotic Enteritis Drugs Study

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      Summary:

      Market Analysis and Insights: Global Poultry Necrotic Enteritis Drugs Market
      Treatment for necrotic enteritis is most commonly administered in the drinking water, with bacitracin, penicillin, and lincomycin most often used.
      Due to the COVID-19 pandemic, the global Poultry Necrotic Enteritis Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Inter Alpha Inhibitor Proteins accounting for % of the Poultry Necrotic Enteritis Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
      China Poultry Necrotic Enteritis Drugs market size is valued at US$ million in 2021, while the US and Europe Poultry Necrotic Enteritis Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Poultry Necrotic Enteritis Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
      The global key manufacturers of Poultry Necrotic Enteritis Drugs include Prometic Life Sciences, BioGaia Probiotics, Fresenius, Actavis, Teva, Bayer International, Alcon, GlaxoSmithKline and Bausch & Lomb Incorporated. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
      Market Segments
      The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
      Segment by Type
      Inter Alpha Inhibitor Proteins
      Antibiotics
      Dietary Supplements
      Segment by Application
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies
      Consequence of Covid-19 Pandemic
      The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Poultry Necrotic Enteritis Drugs market back to the pre-covid levels.
      Trends & Prospects
      In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Outlook
      In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
      Prometic Life Sciences
      BioGaia Probiotics
      Fresenius
      Actavis
      Teva
      Bayer International
      Alcon
      GlaxoSmithKline
      Bausch & Lomb Incorporated
      Frequently Asked Questions
      Which is the most lucrative product segment in the Poultry Necrotic Enteritis Drugs market?
      Which are the prominent strategies of the Poultry Necrotic Enteritis Drugs market players?
      Which factors are increasing the competition in the Poultry Necrotic Enteritis Drugs market?
      Which are the recommendations provided by the Poultry Necrotic Enteritis Drugs industry experts?
      Which region will witness rewarding growth during the forecast period?
      What factors will curb the Poultry Necrotic Enteritis Drugs market growth?
      Which product segment will register the fastest growth rate in the Poultry Necrotic Enteritis Drugs market?
      Which emerging trends will impact the Poultry Necrotic Enteritis Drugs market growth?
      Which are the high-impact rendering factors in the Poultry Necrotic Enteritis Drugs market?
      Which companies will maintain their lead on the Poultry Necrotic Enteritis Drugs market?
      Buy now